P. Blanc

850 total citations
30 papers, 317 citations indexed

About

P. Blanc is a scholar working on Pediatrics, Perinatology and Child Health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, P. Blanc has authored 30 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 7 papers in General Health Professions and 6 papers in Economics and Econometrics. Recurrent topics in P. Blanc's work include Childhood Cancer Survivors' Quality of Life (7 papers), Pharmaceutical studies and practices (7 papers) and Health, Medicine and Society (6 papers). P. Blanc is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (7 papers), Pharmaceutical studies and practices (7 papers) and Health, Medicine and Society (6 papers). P. Blanc collaborates with scholars based in France, United Kingdom and Germany. P. Blanc's co-authors include Gilles Vassal, Régis Gonthier, Marie‐Cécile Le Deley, Darren Hargrave, David M. Ashley, Peter C. Adamson, C. Michel Zwaan, Moustapha Dramé, F. Blanchard and Pamela Kearns and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and European Journal of Cancer.

In The Last Decade

P. Blanc

28 papers receiving 299 citations

Peers

P. Blanc

PPCH

PHEOH

GHP

Clara Fitzgerald United States

Michael A. Liu United States

Nicole Yurgin United States

K Holden United Kingdom

C. Andersen Denmark

Jason Zittel United States

Annalisa Giacalone Italy

Ravi Iyer United States

Maxwell T. Vergo United States

Joanne W. Elena United States

Clara Fitzgerald United States

P. Blanc

22 ×0.2

PPCH

38 ×0.6

PHEOH

20 ×0.3

35 ×0.8

GHP

29 ×0.8

Citations per year, relative to P. Blanc P. Blanc (= 1×) peers Clara Fitzgerald

Countries citing papers authored by P. Blanc

Since Specialization

Citations

This map shows the geographic impact of P. Blanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Blanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Blanc more than expected).

Fields of papers citing papers by P. Blanc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Blanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Blanc. The network helps show where P. Blanc may publish in the future.

Co-authorship network of co-authors of P. Blanc

This figure shows the co-authorship network connecting the top 25 collaborators of P. Blanc. A scholar is included among the top collaborators of P. Blanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Blanc. P. Blanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boutros, Michael, Michaël Baumann, Anna Bigas, et al.. (2024). UNCAN.eu: Toward a European Federated Cancer Research Data Hub. Cancer Discovery. 14(1). 30–35. 2 indexed citations

Geoerger, Birgit, Francisco Bautista, Nicolás André, et al.. (2024). Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART. European Journal of Cancer. 208. 114201–114201. 3 indexed citations

Rojas, Teresa de, Pamela Kearns, P. Blanc, et al.. (2023). Changing incentives to ACCELERATE drug development for paediatric cancer. Cancer Medicine. 12(7). 8825–8837. 3 indexed citations

Rössig, Claudia, Andrew D.J. Pearson, Gilles Vassal, et al.. (2023). Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. 42(3). 253–257. 7 indexed citations

Solary, Éric, P. Blanc, Michael Boutros, et al.. (2022). UNCAN.eu, a European Initiative to UNderstand CANcer. Cancer Discovery. 12(11). 2504–2508. 2 indexed citations

Kaguelidou, Florentia, Jean‐Marc Tréluyer, Claire Le Jeunne, et al.. (2022). Paediatric drug development and evaluation: Existing challenges and recommendations. Therapies. 78(1). 105–114. 4 indexed citations

Kaguelidou, Florentia, Jean‐Marc Tréluyer, Claire Le Jeunne, et al.. (2022). Développement des médicaments en pédiatrie : défis existants et recommandations. Therapies. 78(1). 95–104. 2 indexed citations

Kearns, Pamela, Gilles Vassal, Ruth Ladenstein, et al.. (2019). A European paediatric cancer mission: aspiration or reality?. The Lancet Oncology. 20(9). 1200–1202. 5 indexed citations

Pearson, Andrew D.J., et al.. (2018). 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers. The Lancet Oncology. 19(3). 285–287. 14 indexed citations

10.

Blanc, P., et al.. (2018). Développement des soins palliatifs de proximité à domicile : expérience de trois équipes mobiles. Médecine Palliative. 17(6). 323–330. 1 indexed citations

11.

Vassal, Gilles, et al.. (2017). Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer. European Journal of Cancer. 84. 149–158. 16 indexed citations

12.

Vassal, Gilles, Raphaël F. Rousseau, P. Blanc, et al.. (2014). Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer. European Journal of Cancer. 51(2). 218–224. 51 indexed citations

13.

Vassal, Gilles, C. Michel Zwaan, David M. Ashley, et al.. (2013). New drugs for children and adolescents with cancer: the need for novel development pathways. The Lancet Oncology. 14(3). e117–e124. 60 indexed citations

14.

Jolly, Damien, Rachid Mahmoudi, P. Blanc, et al.. (2012). Ability to predict six-month mortality and inter-tool agreement between four nutritional assessment instruments in the SAFES cohort. European Geriatric Medicine. 3(5). 285–289. 3 indexed citations

15.

Dramé, Moustapha, Nicolas Jovenin, Jean‐Luc Novella, et al.. (2008). Predicting early mortality among elderly patients hospitalised in medical wards via emergency department: The SAFES cohort study. The journal of nutrition health & aging. 12(8). 599–604. 51 indexed citations

16.

Beyens, Marie‐Noëlle, et al.. (2006). Existe-t-il un sur-risque d’accidents médicamenteux chez les sujets âgés atteints de troubles cognitifs ?. NPG. Neurologie, psychiatrie, gériatrie/NPG. 6(35). 21–28. 5 indexed citations

17.

Dorey, Jean‐Michel, et al.. (2005). Plainte et fragilité. NPG. Neurologie, psychiatrie, gériatrie/NPG. 5(28). 33–36. 1 indexed citations

18.

Blanc, P., et al.. (2004). Impact des facteurs de fragilité sur le devenir des sujets âgés de 75 ans et plus opérés d'une prothèse de hanche. Annales de Réadaptation et de Médecine Physique. 47(9). 627–633. 5 indexed citations

19.

Gonthier, Régis, et al.. (2004). Faut-il traiter toutes les maladies de la personne âgée ?. Therapies. 59(2). 227–232. 6 indexed citations

20.

Beauchet, Olivier, et al.. (2002). Impact d’un programme de prévention multidisciplinaire de la chute chez le sujet âgé autonome vivant à domicile, avec analyse avant–après des performances physiques. Annales de Réadaptation et de Médecine Physique. 45(9). 493–504. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact